Skip to content
ClinCalc Pro
Menu
13C-urea breath test

Urea (13C)

Brand names: Diabact UBT, Helicobacter Test INFAI

Urea labelled with the stable carbon-13 isotope is a diagnostic agent used in the urea breath test to detect Helicobacter pylori infection in the stomach.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

If H. pylori is present, its urease enzyme hydrolyses the ingested labelled urea into ammonia and labelled carbon dioxide, which is absorbed and exhaled and then measured in breath samples.

Prescribing in practice

  • The test can give false-negative results if the patient has recently taken proton pump inhibitors, antibiotics or bismuth, so these should be stopped for the recommended washout period beforehand.
  • It is taken after fasting, usually with a citric acid drink to delay gastric emptying and improve test performance.
  • It is a purely diagnostic, non-radioactive agent suitable for confirming eradication after treatment as well as initial diagnosis.

Monitoring

No drug monitoring is required; the test outcome is determined by comparing labelled carbon dioxide in pre- and post-dose breath samples.

Counselling the patient

  • Avoid eating before the test and follow the fasting instructions you are given.
  • Tell the team if you have recently taken acid-suppressing medicines or antibiotics, as these can affect the result.

Evidence & guidelines

The carbon-13 urea breath test is endorsed by NICE as a non-invasive method for diagnosing H. pylori and confirming eradication.

Reference: NICE CG184; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.